Lung Cancer Symposium:Evolving Strategies in Lung CancerDiagnosis and Treatment

1504 College WayLexington, KY 40502

Course Overview: The purpose of the Evolving Strategies in Lung Cancer Diagnosis

and Treatment Symposium is to educate physicians and healthcare professionals

about the most innovative treatment methods for patients diagnosed with Non-Small

Cell Lung Cancer (NSCLC). Along with offering a morning plenary session, two

break-out sessions will be conducted concurrently in the afternoon that will focus on

symptom management/palliative care issues and diagnostic/research techniques.

Lung Cancer Symposium:Evolving Strategies in Lung Cancer Diagnosis and Treatment

Friday, November 7, 2008

Embassy Suites Hotel, Lexington, Kentucky

Register at www.ukyce.com or call 859-257-5320, ext. 80337

7.25 AMA PRA Category 1 CreditsTM

The faculty of the Multidisciplinary Lung Cancer Program at the UK Markey Cancer Center recognizes the need to educate physicians and healthcare professionals about the diagnostic and treatment approaches for Non-Small Cell Lung Cancer. Statistics reveal that Kentucky leads the nation in deaths and incidences of lung cancer. Nationally, lung cancer causes more deaths than breast, colon, and prostate cancers combined. Thus, defi ning the appropriate work-up and therapy for this devastating disease is of paramount importance to primary care physicians, medical and radiation oncologists, pulmonologists, surgeons and other related professionals. Along with the therapeutic and diagnostic aspects of the NSCLC, it is also essential for physicians to understand the role of symptom management and palliative care. This symposium seeks to expand our under-standing of the treatment of NSCLC. Overall, the faculty considers it essential to provide a comprehensive educational program for physicians and healthcare professionals in Kentucky and the region.

Course Director:Timothy Wm. Mullett, MDUniversity of Kentucky Chandler Medical CenterLexington, KY

Eric Bensadoun, MDUniversity of Kentucky Chandler Medical CenterLexington, KY

Hak Choy, MDUniversity of Texas SouthwesternDallas, TX

Kristy Deep, MDUniversity of Kentucky Chandler Medical CenterLexington, KY

Frank Greco, MDSarah Cannon Cancer CenterNashville, TN

Jay Grider, MDUniversity of Kentucky Chandler Medical CenterLexington, KY

Goetz Kloecker, MDUniversity of LouisvilleLouisville, KY

Steve Passik, PhDMemorial Sloan-Kettering Cancer CenterNew York, NY

David Rice, MDUniversity of Texas MD Anderson Cancer CenterHouston, TX

Jay Zwischenberger, MDUniversity of Kentucky Chandler Medical CenterLexington, KY

Faculty

Lung cancer is one of the most common cancers in

the world today. In 2007, lung cancer will account

for approximately 15% of all cancer diagnoses and

29% of all cancer deaths. It is the second most

diagnosed cancer in men and woman (after pros-

tate and breast, respectively), but it is the number

one cause of death from cancer each year in both men and women.

The Markey Cancer Center is very pleased to partner with the Lexington

Foundation in presenting what I believe to be an outstanding CME

program focused on this important disease.

A distinguished faculty composed of UK physicians and experts from

some of America’s best known cancer programs will discuss the ap-

proach to lung cancer, from innovative radiation oncology for non-small

cell lung cancer; techniques for symptom management and palliative

care in all stages of NSCLC; management of lung cancer in elderly

patients; the role of new biologic agents; cancer pain management,

and the solitary pulmonary nodule revisited. The afternoon session will

allow for the attendees to participate in breakout sessions to discuss

symptom management and diagnostic research.

I hope you will join us on November 7, 2008, for what I think will be a

broad-based and valuable education experience.

Timothy W. Mullett, M.D.

Director, Multidisciplinary Lung Cancer Program

Director, Lung Transplant Program

University of Kentucky

According to the Center for Disease Control, more

people die from lung cancer that any other type

of cancer. This is true for both men and women.

Smoking is the primary factor, but not all cancer

patients have a history of smoking. The Lexington

Cancer Foundation, Inc. is pleased to partner with

the UK Markey Cancer Center in presenting the 2008 Lung Cancer Sym-

posium: Evolving Strategies in Lung Cancer Diagnosis and Treatment.

We are committed to providing local high-quality continuing education

to physicians and medical professionals from world class authorities.

Our distinguished 2008 faculty includes experts from UK Markey Cancer

Center, MD Anderson, Sloan Kettering, and more. Topics range from

diagnostics, treatment, symptom management, and research.

The LCFI is a non-profi t organization committed to raising awareness

and funds for cancer research, education, and patient care. Please do

not hesitate to register and make your hotel reservations, as we expect

this to be a sold out event.

Brenda Rice, President

The Lexington Cancer Foundation, Inc.

Evolving Strategies in LungCancer Diagnosis and Treatment

November 7, 2008

Embassy Suites HotelLexington, Kentucky

7.25 AMA PRA Category 1 CreditsTM

Accredited by:

Lung Cancer Symposium:

Accredited by:

CO

ME J O

I N US !

Objectives & Program

Accommodations: Embassy Suites Hotel (Conference Location)

1801 Newtown Pike, Lexington, Kentucky

A block of rooms is available at $152 plus tax per night for single and

double occupancy. Please make your reservations by October 8, 2008, to

receive this rate. Call 859-451-5000 and ask for the U of KY Lung Cancer

Symposium.

Registration & Fees:

The course registration fee includes tuition, continental breakfast,

coffee breaks, lunch, and the course syllabus.

Registration Fee (Advance Tuition)

$75: Physicians $50: Non-Physicians

Late Registration Fee

(Postmarked after October 27 and on-site registration)

$100: Physicians $75: Non-Physicians

Registration Options:

Online: www.ukyce.com

Phone: 859-257-5320, ext. 80337

Fax: Please complete the Conference Registration Form and fax to

859-323-2920. This option is available for payment with a credit card only.

To register and pay by mail: Complete the Conference Registration Form,

make your check payable to “University of Kentucky”, and mail to:

University of Kentucky

ATTN: MSL09009

One Quality Street

Sixth Floor

Lexington, Kentucky 40507

Disability Statement:

If you require any special physical arrangements to attend this activity,

please call 859-257-5320, ext. 80337.

Refund and Cancellation Policy:

A full refund, less a $25 processing fee, will be made if notice of

withdrawal is received by November 2, 2008. We reserve the right

to cancel or substitute topics or speakers.

For more information please call Deloris Mercer at

859-257-5320, ext. 80337.

Friday, November 7, 2008

7:00 – 8:00 am Registration & Breakfast

8:00 – 8:15 am Welcome & Overview

8:15 – 9:00 am The Solitary Pulmonary Nodule Revisited Eric Bensadoun, MD

9:00 – 9:45 am Lung Cancer Staging 2009: What’s New? David Rice, MD

9:45 –10:00 am Break

10:00 – 10:45 am The Role of New Biologic Agents Frank Greco, MD

10:45 – 11:30 am Advanced Technology in Radiation Therapy for Lung Cancer Hak Choy, MD

11:30 am – 12:15 pm Cancer Pain Management in a Substance Abusing Society Steve Passik, PhD

12:15 – 1:30 pm Lunch

Breakout Sessions/Concurrent Talks (Participants free to move between rooms)

Symptom Management 1:30 – 2:15 pm Pain Control Advances for Patients with Neoplasm Related Chronic Pain

Jay Grider, MD

2:15 – 3:00 pm Treating the Cancer Patient With a History of Drug Abuse:A Case-Based Presentation

Steve Passik, PhD

3:00 – 3:45 pm Inpatient Management of Palliative Care Kristy Deep, MD

Diagnostic Research 1:30 – 2:15 pm Screening and Prevention of Lung Cancer Goetz Kloecker, MD

2:15 – 3:00 pm TBA

3:00 – 3:45 pm Building Your Multi-Modality Practice Timothy Mullett, MD

3:45 – 4:00 pm Break

4:00 – 5:00 pm Panel/Case Discussions

Disclosure Policy: Faculty presenters of continuing education programs sponsored by the University of Kentucky College of Medicine are expected to dis-close any real or perceived confl ict of interest. Cop-ies of faculty disclosures are included in participant program materials or given prior to the lecture.

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and the Lexington Cancer Foundation. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presenta-tions is provided solely by presenters who have been selected for presentations because of recognized expertise in their fi eld.

Non-Physicians: The University of Kentucky College of Medicine will provide a certifi cate of attendance for non-physicians. This activity was designated for 7.25 AMA PRA Category 1 CreditsTM.

Target Audience: Primary Care Physicians

(Internal Medicine, Family Practice, General

Practice), CT Surgeons, Pulmonologists,

Medical Oncologists, Radiation Oncologists,

General Surgeons, Physician Assistants,

Nurse Practitioners, and Registered Nurses.

• Update participants on the current status of new biologic agents in the treatment of non-small cell lung cancer.

• Discuss innovative radiation oncology treatments for non-small cell lung cancer.

• Describe techniques for symptom management and palliative care in all stages of NSCLC.

• Defi ne and discuss the solitary pulmonary nodule in the diagnosis of NSCLC.

• Discuss the management of lung cancer in the elderly patient.

• Explain the management techniques for high-risk patients.

Registration Form

Mail or Fax Conference Registration Form to:

University of Kentucky

Attn: MLS09009

One Quality Street

Sixth Floor

Lexington, Kentucky 40507

Fax: 859-323-2920

Evolving Strategies in Lung Cancer Diagnosis and Treatment

Registration Fees (Advance Tuition)

___ $75: Physicians

___ $50: Non-Physicians

(Postmarked after October 27 and on-site registration)

___ $100: Physicians

___ $75: Non-Physicians

First Name, Middle Initial Last Name Credentials

Specialty Hospital Affi liation

Address

City State/Province Zip Code

Offi ce Telephone Fax

Email

Please Indicate Any Special Needs (Including Dietary Restictions)

If paying by Visa or MasterCard, pleasefi ll out the information to the right.

___ M/C

___ VISA

Billing Address If Different From Above

Name On Card

Card Number Expiration Date

Signature

Date Received Check No/Approval CD Amount Confi rmation Sent Initials

Registration & Fees

Photograph of Lexington skyline by Eleanor Coonce, courtesy Lexington Convention and Visitors Bureau

Seminar Committee MembersBeth Gudeman, Chair Kristi Martin Gwen Langley Ginny MayGlenna Hughes Holly Arnold

Registration Form

Evolving Strategies in Lung Cancer Diagnosis and Treatment

To Register Online: www.ukyce.com

Make check payable to “University of Kentucky”.